Development of a DNA Methylation–Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma

PURPOSE: A challenge in the diagnosis of renal cell carcinoma (RCC) is to distinguish chromophobe RCC (chRCC) from benign renal oncocytoma, because these tumor types are histologically and morphologically similar, yet they require different clinical management. Molecular biomarkers could provide a w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Precis Oncol
Main Authors: Brennan, Kevin, Metzner, Thomas J., Kao, Chia-Sui, Massie, Charlie E., Stewart, Grant D., Haile, Robert W., Brooks, James D., Hitchins, Megan P., Leppert, John T., Gevaert, Olivier
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529536/
https://ncbi.nlm.nih.gov/pubmed/33015531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados